Tags:Varlilumab 代理商,Varlilumab 价格,Varlilumab 供应商, Varlilumab supplier,Varlilumab purchase,Varlilumab 购买,Varlilumab 销售
Description
Varlilumab is a fully human monoclonal antibody (mAb) that targets CD27, a critical molecule in the activation pathway of lymphocytes. Like CD40, CD27 can be effectively manipulated with activating antibodies to induce potent anti-tumor responses, and may result in less toxicities due to its restricted expression and regulation. Varlilumab is a novel, first-in-class, agonist CD27 antibody that stimulates the CD27 pathway, which results in T-cell activation and antitumor activity in tumor models. This first-in-human, dose-escalation and expansion study evaluated the safety, pharmacology, and activity of varlilumab in patients with advanced solid tumors.
Catalog No.
DHD72201
Host species
Homo sapiens
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
0.63 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
CD27L receptor, TNFRSF7, T14, CD27 antigen, Tumor necrosis factor receptor superfamily member 7, CD27, T-cell activation antigen CD27
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P26842
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
1F5, CDX-1127, CAS: 1393344-72-3
Note
For research use only. Not suitable for clinical or therapeutic use.
关键字: Varlilumab;伐立鲁单抗;1393344-72-3;TNFRSF7, T14;CD27;
武汉佰乐博生物(Biolab Reagents )作为普健生物旗下控股子品牌,专注于引进、整合全球业内高品质蛋白、抗体产品。作为法国ProteoGenix、Antibodysystem品牌亚洲区独家运营代理商。提供近2万种以蛋白、抗体为核心的生命科学试剂,旨在为生命科学科研工作者提供专业、全面、可靠的试剂产品。